Trial intelligence / Profile preview

Pexidartinib in adults with symptomatic tenosynovial giant cell tumor not amenable to surgery

CTR20201220Phase 3Active

Sponsor

Daiichi Sankyo Co., Ltd.

Start

Nov 2020

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1